Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Memogain is a galantamine pro-drug having dramatically reduced adverse effects and enhanced efficacy - Maelicke_2010_J.Mol.Neurosci_40_135 |
| Author(s) : Maelicke A , Hoeffle-Maas A , Ludwig J , Maus A , Samochocki M , Jordis U , Koepke AK |
| Ref : Journal of Molecular Neuroscience , 40 :135 , 2010 |
| Abstract : Maelicke_2010_J.Mol.Neurosci_40_135 |
| ESTHER : Maelicke_2010_J.Mol.Neurosci_40_135 |
| PubMedSearch : Maelicke_2010_J.Mol.Neurosci_40_135 |
| PubMedID: 19669943 |
| Title : Localization by site-directed mutagenesis of a galantamine binding site on alpha7 nicotinic acetylcholine receptor extracellular domain - Ludwig_2010_J.Recept.Signal.Transduct.Res_30_469 |
| Author(s) : Ludwig J , Hoffle-Maas A , Samochocki M , Luttmann E , Albuquerque EX , Fels G , Maelicke A |
| Ref : J Recept Signal Transduct Res , 30 :469 , 2010 |
| Abstract : Ludwig_2010_J.Recept.Signal.Transduct.Res_30_469 |
| ESTHER : Ludwig_2010_J.Recept.Signal.Transduct.Res_30_469 |
| PubMedSearch : Ludwig_2010_J.Recept.Signal.Transduct.Res_30_469 |
| PubMedID: 21062106 |
| Title : Nicotinic receptor modulation. - |
| Author(s) : Albuquerque EX , Pereira EF , Samochocki M , Alkondon M , Christoph U , Maelicke A |
| Ref : Cholinergic Mechanisms, CRC Press :297 , 2004 |
| PubMedID: |
| Title : Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors - Samochocki_2003_J.Pharmacol.Exp.Ther_305_1024 |
| Author(s) : Samochocki M , Hoffle A , Fehrenbacher A , Jostock R , Ludwig J , Christner C , Radina M , Zerlin M , Ullmer C , Pereira EF , Lubbert H , Albuquerque EX , Maelicke A |
| Ref : Journal of Pharmacology & Experimental Therapeutics , 305 :1024 , 2003 |
| Abstract : Samochocki_2003_J.Pharmacol.Exp.Ther_305_1024 |
| ESTHER : Samochocki_2003_J.Pharmacol.Exp.Ther_305_1024 |
| PubMedSearch : Samochocki_2003_J.Pharmacol.Exp.Ther_305_1024 |
| PubMedID: 12649296 |
| Title : Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease - Maelicke_2001_Biol.Psychiatry_49_279 |
| Author(s) : Maelicke A , Samochocki M , Jostock R , Fehrenbacher A , Ludwig J , Albuquerque EX , Zerlin M |
| Ref : Biological Psychiatry , 49 :279 , 2001 |
| Abstract : Maelicke_2001_Biol.Psychiatry_49_279 |
| ESTHER : Maelicke_2001_Biol.Psychiatry_49_279 |
| PubMedSearch : Maelicke_2001_Biol.Psychiatry_49_279 |
| PubMedID: 11230879 |
| Title : Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease - Maelicke_2000_Behav.Brain.Res_113_199 |
| Author(s) : Maelicke A , Schrattenholz A , Samochocki M , Radina M , Albuquerque EX |
| Ref : Behavioural Brain Research , 113 :199 , 2000 |
| Abstract : Maelicke_2000_Behav.Brain.Res_113_199 |
| ESTHER : Maelicke_2000_Behav.Brain.Res_113_199 |
| PubMedSearch : Maelicke_2000_Behav.Brain.Res_113_199 |
| PubMedID: 10942046 |
| Title : Galantamine is an allosterically potentiating ligand of the human alpha4\/beta2 nAChR - Samochocki_2000_Acta.Neurol.Scand.Suppl_176_68 |
| Author(s) : Samochocki M , Zerlin M , Jostock R , Groot Kormelink PJ , Luyten WH , Albuquerque EX , Maelicke A |
| Ref : Acta Neurologica Scandinavica Supplementum , 176 :68 , 2000 |
| Abstract : Samochocki_2000_Acta.Neurol.Scand.Suppl_176_68 |
| ESTHER : Samochocki_2000_Acta.Neurol.Scand.Suppl_176_68 |
| PubMedSearch : Samochocki_2000_Acta.Neurol.Scand.Suppl_176_68 |
| PubMedID: 11261808 |